Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 7/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 6/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.56 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.50 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1121537 | 0.98 | GSR (0.61) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL10849502 | 0.89 | GSR (0.53) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL9442168 | 0.88 | GSR (0.52) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL1121505 | 0.85 | GSR (0.53) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL21165452 | 0.84 | ALDH1A1 (0.49) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL2854879 | 0.83 | GSR (0.61) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL2680058 | 0.83 | GSR (0.61) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL11663498 | 0.82 | GSR (0.55) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL10822039 | 0.81 | GSR (0.59) | GSRCA1CA2GABRA1GABRB1 | |
| SCHEMBL10821857 | 0.81 | GSR (0.59) | GSRCA1CA2GABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624156-B2 | Processes for forming epoxy resin compositions and separation processes | Westlake Epoxy Inc. (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4688949-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4688950-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211145-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. (US) | 2024-10-10 | — | — | WO | disclosed |
| WO-2024211144-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-20240336722-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. | 2024-10-10 | — | — | US | disclosed |
| US-20240336723-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | Westlake Epoxy Inc. | 2024-10-10 | — | — | US | disclosed |
| EP-2547784-B1 | HIGH ENERGY RADIATION INSENSITIVE ANALYTE SENSORS | EDWARDS LIFESCIENCES CORP (US) | 2016-11-30 | — | — | EP | disclosed |
| US-8895252-B2 | High energy radiation insensitive analyte sensors | EDWARDS LIFESCIENCES CORPORATION (US) | 2014-11-25 | — | — | US | disclosed |
| US-20130189720-A1 | HIGH ENERGY RADIATION INSENSITIVE ANALYTE SENSORS | EDWARDS LLIFESCIENCES CORPORATION (US) | 2013-07-25 | — | — | US | disclosed |
| US-4368315-A | AGITATED TWO-PHASE MIXTURE OF ORGANIC SOLVENT AND WATER CONTAINING STRONG BASE | GENERAL ELECTRIC COMPANY (US) | 1983-01-11 | — | — | US | disclosed |
| US-4360659-A | Non-catalyzed interfacial polycondensation polycarbonate process | GENERAL ELECTRIC COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
| EP-0058217-A1 | A process for producing a random copolymer and random copolymer | PHILLIPS PETROLEUM COMPANY (US) | 1982-08-25 | — | — | EP | disclosed |
| EP-0046558-A2 | Flame retardant alkylated aromatic polycarbonate compositions | Mobay Chemical Corporation (US) | 1982-03-03 | — | — | EP | disclosed |
| US-4316980-A | USING A QUATERNARY AMMONIUM SALT CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1982-02-23 | — | — | US | disclosed |
| US-4277591-A | ORGANOLITHIUM INITIATOR AND AN ORGANIC COMPOUND OF SODIUM, POTASSIUM, RUBIDIUM, OR CESIUM | PHILLIPS PETROLEUM COMPANY (US) | 1981-07-07 | — | — | US | disclosed |
| EP-0013904-A1 | Process for the preparation of polycarbonates | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4104196-A | Nonabsorbable antioxidant method | DYNAPOL (US) | 1978-08-01 | — | — | US | disclosed |
| US-4020113-A | 4,4'-Methylenebis(2,6-diisobutylphenol) | THE QUAKER OATS COMPANY (US) | 1977-04-26 | — | — | US | disclosed |
| US-3994828-A | Nonabsorbable antioxidant | DYNAPOL CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336722-A1 | PROCESSES FOR FORMING EPOXY RESIN COMPOSITIONS AND SEPARATION PROCESSES | EPHX2, EPHX1, HDHD5 | GSR 3968/4885CA1 389/4885CA2 1461/4885 |
| US-12624156-B2 | Processes for forming epoxy resin compositions and separation processes | EPHX1, EPHX2, RER1 | GSR 2300/4885CA1 249/4885CA2 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.